8-K Starling Oncology, Inc. 2026-09-02: filing_form_type
| Value | {"value": "8-K"} |
|---|---|
| Period | (as of 2026-09-02) |
| Status | current |
| Entity | 8-K Starling Oncology, Inc. 2026-09-02 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/0001079973-26-001208-in
Retrieved: 2026-09-02T12:14:25.868162+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/0373342b-07fe-4e36-9ec0-fe6e3e95b9fd
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1799191/000107997326001208/0001079973-26-001208-in
Retrieved: 2026-09-02T12:14:25.868162+02:00
Raw response sha256:
5d746ee7c7e0bbf7c8f73767a04df47f…Cite as: FACTANKER, https://factanker.com/fact/0373342b-07fe-4e36-9ec0-fe6e3e95b9fd
History
- no predecessors — first report